Similar articles

• Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor.

  Lucca A, Lucini V, Catalano M, Alfano M, Smeraldi E. Lucca A, et al. Neuropsychobiology. 1994;29(3):108-11. doi: 10.1159/000119071. Neuropsychobiology. 1994. PMID: 8022529 Clinical Trial.
• [Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].

  Cottencin O, Regnaut N, Thévenon-Gignac C, Thomas P, Goudemand M, Debruille C, Robert H. Cottencin O, et al. Encephale. 1995 Mar-Apr;21(2):141-5. Encephale. 1995. PMID: 7781585 French.
• Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.

  Hrdina PD. Hrdina PD. J Psychiatry Neurosci. 1991 Jul;16(2 Suppl 1):10-8. J Psychiatry Neurosci. 1991. PMID: 1931931 Free PMC article. Review. No abstract available.
• Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement.

  Celada P, Dolera M, Alvarez E, Artigas F. Celada P, et al. J Affect Disord. 1992 Aug;25(4):243-9. doi: 10.1016/0165-0327(92)90082-h. J Affect Disord. 1992. PMID: 1385505
• Treatment guidelines for valproate in bipolar and schizoaffective disorders.

  McElroy SL, Keck PE Jr. McElroy SL, et al. Can J Psychiatry. 1993 Apr;38(3 Suppl 2):S62-6. Can J Psychiatry. 1993. PMID: 8500081 Review.